Cargando…

Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis

Resveratrol, a trans-stilbene polyphenolic compound and its synthetic analogs are widely used bioactive molecules due to their remarkable chemo-preventive potential. Here, we have identified a novel synthetic trans-stilbene compound, Z-DAN-11 ((Z)-3-(3, 4-dimethoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Parida, Pravat Kumar, Mahata, Barun, Santra, Abhisek, Chakraborty, Sohini, Ghosh, Zhumur, Raha, Sanghamitra, Misra, Anup Kumar, Biswas, Kaushik, Jana, Kuladip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906627/
https://www.ncbi.nlm.nih.gov/pubmed/29670107
http://dx.doi.org/10.1038/s41419-018-0476-2
_version_ 1783315411937263616
author Parida, Pravat Kumar
Mahata, Barun
Santra, Abhisek
Chakraborty, Sohini
Ghosh, Zhumur
Raha, Sanghamitra
Misra, Anup Kumar
Biswas, Kaushik
Jana, Kuladip
author_facet Parida, Pravat Kumar
Mahata, Barun
Santra, Abhisek
Chakraborty, Sohini
Ghosh, Zhumur
Raha, Sanghamitra
Misra, Anup Kumar
Biswas, Kaushik
Jana, Kuladip
author_sort Parida, Pravat Kumar
collection PubMed
description Resveratrol, a trans-stilbene polyphenolic compound and its synthetic analogs are widely used bioactive molecules due to their remarkable chemo-preventive potential. Here, we have identified a novel synthetic trans-stilbene compound, Z-DAN-11 ((Z)-3-(3, 4-dimethoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl) acrylonitrile) which shows remarkable efficacy in blocking tumor growth and progression both in vitro and in vivo. Z-DAN-11 inhibits proliferation of cancer cells in vitro through microtubule depolymerization that induced G2/M arrest and consequently leads to apoptotic cell death. More importantly, Z-DAN-11 shows limited cytotoxicity to normal cells as compared to cancer cells. Quite interestingly, we have found that Z-DAN-11-mediated ROS production helps in dramatic alteration in the mitochondrial redox status which critically contributes to the apoptosis. Mechanistic studies reveal that Z-DAN-11 induces the expression of pro-apoptotic proteins and decreases anti-apoptotic protein expression that decisively helps in the activation of caspase 8, caspase 9, and caspase 3, leading to cleavage of PARP1 and cell death via intrinsic and extrinsic pathways of apoptosis. Moreover, Z-DAN-11-mediated apoptosis of cancer cells is through a partial p53-dependent pathway, since both HCT116 p53(−/−) cells as well as p53-silenced cells (siRNA) were able to block apoptosis partially but significantly. Importantly, Z-DAN-11 also imparts its anti-tumorigenic effect by inhibiting clonogenic property and anchorage-independent growth potential of cancer cells at concentrations at least 10 times lower than that required for inducing apoptosis. Finally, in vivo study with immuno-competent syngeneic mice shows Z-DAN-11 to be able to impede tumor progression without any adverse side-effects. Hence, we identified a novel, synthetic trans-stilbene derivative with anti-tumorigenic potential which might tremendously help in devising potential therapeutic strategy against cancer.
format Online
Article
Text
id pubmed-5906627
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-59066272018-06-05 Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis Parida, Pravat Kumar Mahata, Barun Santra, Abhisek Chakraborty, Sohini Ghosh, Zhumur Raha, Sanghamitra Misra, Anup Kumar Biswas, Kaushik Jana, Kuladip Cell Death Dis Article Resveratrol, a trans-stilbene polyphenolic compound and its synthetic analogs are widely used bioactive molecules due to their remarkable chemo-preventive potential. Here, we have identified a novel synthetic trans-stilbene compound, Z-DAN-11 ((Z)-3-(3, 4-dimethoxyphenyl)-2-(3, 4, 5-trimethoxyphenyl) acrylonitrile) which shows remarkable efficacy in blocking tumor growth and progression both in vitro and in vivo. Z-DAN-11 inhibits proliferation of cancer cells in vitro through microtubule depolymerization that induced G2/M arrest and consequently leads to apoptotic cell death. More importantly, Z-DAN-11 shows limited cytotoxicity to normal cells as compared to cancer cells. Quite interestingly, we have found that Z-DAN-11-mediated ROS production helps in dramatic alteration in the mitochondrial redox status which critically contributes to the apoptosis. Mechanistic studies reveal that Z-DAN-11 induces the expression of pro-apoptotic proteins and decreases anti-apoptotic protein expression that decisively helps in the activation of caspase 8, caspase 9, and caspase 3, leading to cleavage of PARP1 and cell death via intrinsic and extrinsic pathways of apoptosis. Moreover, Z-DAN-11-mediated apoptosis of cancer cells is through a partial p53-dependent pathway, since both HCT116 p53(−/−) cells as well as p53-silenced cells (siRNA) were able to block apoptosis partially but significantly. Importantly, Z-DAN-11 also imparts its anti-tumorigenic effect by inhibiting clonogenic property and anchorage-independent growth potential of cancer cells at concentrations at least 10 times lower than that required for inducing apoptosis. Finally, in vivo study with immuno-competent syngeneic mice shows Z-DAN-11 to be able to impede tumor progression without any adverse side-effects. Hence, we identified a novel, synthetic trans-stilbene derivative with anti-tumorigenic potential which might tremendously help in devising potential therapeutic strategy against cancer. Nature Publishing Group UK 2018-04-18 /pmc/articles/PMC5906627/ /pubmed/29670107 http://dx.doi.org/10.1038/s41419-018-0476-2 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Parida, Pravat Kumar
Mahata, Barun
Santra, Abhisek
Chakraborty, Sohini
Ghosh, Zhumur
Raha, Sanghamitra
Misra, Anup Kumar
Biswas, Kaushik
Jana, Kuladip
Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
title Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
title_full Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
title_fullStr Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
title_full_unstemmed Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
title_short Inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving G2/M arrest, and p53-dependent apoptosis
title_sort inhibition of cancer progression by a novel trans-stilbene derivative through disruption of microtubule dynamics, driving g2/m arrest, and p53-dependent apoptosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906627/
https://www.ncbi.nlm.nih.gov/pubmed/29670107
http://dx.doi.org/10.1038/s41419-018-0476-2
work_keys_str_mv AT paridapravatkumar inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT mahatabarun inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT santraabhisek inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT chakrabortysohini inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT ghoshzhumur inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT rahasanghamitra inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT misraanupkumar inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT biswaskaushik inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis
AT janakuladip inhibitionofcancerprogressionbyanoveltransstilbenederivativethroughdisruptionofmicrotubuledynamicsdrivingg2marrestandp53dependentapoptosis